Home/Filings/4/0001127602-24-029380
4//SEC Filing

Guerrero Ramiro 4

Accession 0001127602-24-029380

CIK 0001878313other

Filed

Dec 12, 7:00 PM ET

Accepted

Dec 13, 5:15 PM ET

Size

6.9 KB

Accession

0001127602-24-029380

Insider Transaction Report

Form 4
Period: 2024-12-13
Transactions
  • Purchase

    Common Stock

    2024-12-13$1.87/sh+53,418$99,998514,970 total
  • Purchase

    Warrants

    2024-12-13$2.08/sh+53,418$111,10953,418 total
    Exercise: $2.08From: 2025-06-13Exp: 2030-06-13Common Stock (53,418 underlying)
Footnotes (2)
  • [F1]The common stock was purchased pursuant to a Securities Purchase Agreement and were issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024.
  • [F2]These warrants were purchased pursuant to a Securities Purchase Agreement and were deemed options issued under the Issuer's 2021 Equity Incentive Plan on December 13, 2024. The options are exercisable beginning on the six month anniversary of the issuance date and expire 5-years after the initial exercise date.

Issuer

MAIA Biotechnology, Inc.

CIK 0001878313

Entity typeother

Related Parties

1
  • filerCIK 0001913253

Filing Metadata

Form type
4
Filed
Dec 12, 7:00 PM ET
Accepted
Dec 13, 5:15 PM ET
Size
6.9 KB